search
Back to results

Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED) (HAPIFED)

Primary Purpose

Binge Eating Disorder, Bulimia Nervosa, Eating Disorder

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
HAPIFED
CBT-E
Sponsored by
Federal University of São Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Binge Eating Disorder focused on measuring BED, Binge Eating Disorer, BN, Bulimia Nervosa, Obesity

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of threshold or subthreshold for Bulimia Nervosa or Binge Eating Disorder (DSM-5/ICD-11)
  • BMI between ≥ 27 and < 40

Exclusion Criteria:

  • Diagnosis of psychosis, bipolar disorder or substance abuse dependence and/or a high level of suicide risk.
  • Use of weight loss medication or medications that interfere with appetite.
  • Cushing or Prader-Willi syndromes
  • History of bariatric surgery
  • Patients who are already in treatment

Sites / Locations

  • Universidade Federal de Sao Paulo (UNIFESP)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

HAPIFED

CBT-E

Arm Description

HAPIFED therapy

CBT-E therapy

Outcomes

Primary Outcome Measures

Sustained change weight (for less) of 5% of previous body weight. This is a level known to improve physical health (metabolic) outcomes.
Change of 5% of body weight.

Secondary Outcome Measures

Change in binge eating frequency
Change (for less) in binge eating frequency as measured on the Eating Disorder Examintaion Questionnaire
Severity of loss of control over eating
Change (for less) in the Global (total) Loss of Control over Eating Scale (LOCES) score
Change in severity of binge eating
Binge eating severity as measured by a reduced total score on the Binge Eating Scale questionnaire
Improved metabolic indicators of weight management
Waist and Hip circumference and blood markers (Blood fasting lipid profile, fasting glucose matched with insulin, liver function tests, electrolytes, urea, uric acid and creatinine.
Change in the levels of depression, anxiety and stress.
Changed level of depression, anxiety and stress as measured on the Depression, Anxiety and Stress Scale 21 item questionnaire - subscale scores of depression, anxiety and stress
Health related quality of life
Improved physical and mental health related quality of life as measured by increased scores on the Short Form 12-item survey (SF-12) Physical and Mental Health Component scores

Full Information

First Posted
June 1, 2015
Last Updated
December 23, 2021
Sponsor
Federal University of São Paulo
Collaborators
University of Western Sydney
search

1. Study Identification

Unique Protocol Identification Number
NCT02464345
Brief Title
Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED)
Acronym
HAPIFED
Official Title
A Randomised Controlled Trial of a New Integrated Approach to Management of Eating and Weight Disorders, Namely a Healthy APproach to weIght Management and Food in Eating Disorders Compared to Cognitive Behaviour Therapy Enhanced.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
July 7, 2015 (Actual)
Primary Completion Date
March 31, 2019 (Actual)
Study Completion Date
March 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of São Paulo
Collaborators
University of Western Sydney

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators have developed a new integrated therapy, namely a Healthy Approach to weIght management and Food in Eating Disorders (HAPIFED). HAPIFED is an enhanced behavioral weight loss therapy integrated with CBT for the management of EDs. HAPIFED uses CBT to treat ED behaviors and body image distress, whilst simultaneously emphasize a healthy lifestyle, the role of food and physical activity in mood regulation, and revised but clinically meaningful goals for weight loss. The investigators propose a randomized controlled trial (RCT) that will compare HAPIFED to CBT-E in people with obesity and either BN or BED. The two main aims will be to reduce symptoms of ED and to improve weight management. The RCT will be conducted in Sydney and in São Paulo with a one year follow-up.
Detailed Description
In sum, a new approach in management of the increasing numbers of obese people with BN and BED is needed. The investigators propose a RCT that will compare a novel therapy HAPIFED with the current 'gold-standard' trans diagnostic treatment, CBT-E. HAPIFED has been developed by the CIs and is based on recent developments in psychological approaches to obesity in general (as highlighted in Casazza et al.'s (2013) paper on "Myths, presumptions and facts about obesity") and in people with co-morbid obesity and BN or BED. Unlike CBT-E, it allows reduced energy intake and education around specific food choices - a necessary element in weight loss.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Binge Eating Disorder, Bulimia Nervosa, Eating Disorder
Keywords
BED, Binge Eating Disorer, BN, Bulimia Nervosa, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
98 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HAPIFED
Arm Type
Experimental
Arm Description
HAPIFED therapy
Arm Title
CBT-E
Arm Type
Active Comparator
Arm Description
CBT-E therapy
Intervention Type
Behavioral
Intervention Name(s)
HAPIFED
Intervention Description
HAPIFED is adapted from CBT to promote a positive relationship with food, eating and activity, appetite awareness, and weight loss to be achieved over a longer and more intensive period of therapy, thus recognizing the importance of longer-term therapy in weight loss (Casazza et al., 2013). Notably, HAPIFED is also multidisciplinary. Clinical practice and consensus views are to utilize the special expertise of dietitians and other allied health professionals (Robinson, 2009).
Intervention Type
Behavioral
Intervention Name(s)
CBT-E
Intervention Description
CBT-E therapy
Primary Outcome Measure Information:
Title
Sustained change weight (for less) of 5% of previous body weight. This is a level known to improve physical health (metabolic) outcomes.
Description
Change of 5% of body weight.
Time Frame
Baseline, 25-weeks (end) treatment, 6 and12 months follow-up.
Secondary Outcome Measure Information:
Title
Change in binge eating frequency
Description
Change (for less) in binge eating frequency as measured on the Eating Disorder Examintaion Questionnaire
Time Frame
Baseline, 14 weeks (mid) treatment, and 25 weeks (end) treatment, 6 and 12 months follow-up.
Title
Severity of loss of control over eating
Description
Change (for less) in the Global (total) Loss of Control over Eating Scale (LOCES) score
Time Frame
Baseline, 14 weeks (mid) treatment, and 25 weeks (end) treatment, 6 and 12 months follow-up.
Title
Change in severity of binge eating
Description
Binge eating severity as measured by a reduced total score on the Binge Eating Scale questionnaire
Time Frame
Baseline, 14 weeks (mid) treatment, and 25 weeks (end) treatment, 6 and 12 months follow-up.
Title
Improved metabolic indicators of weight management
Description
Waist and Hip circumference and blood markers (Blood fasting lipid profile, fasting glucose matched with insulin, liver function tests, electrolytes, urea, uric acid and creatinine.
Time Frame
Baseline, 25 weeks (end) treatment
Title
Change in the levels of depression, anxiety and stress.
Description
Changed level of depression, anxiety and stress as measured on the Depression, Anxiety and Stress Scale 21 item questionnaire - subscale scores of depression, anxiety and stress
Time Frame
Baseline, 14 weeks (mid) treatment, and 25 weeks (end) treatment, 6 and 12 months follow-up.
Title
Health related quality of life
Description
Improved physical and mental health related quality of life as measured by increased scores on the Short Form 12-item survey (SF-12) Physical and Mental Health Component scores
Time Frame
Baseline, 14 weeks (mid) treatment, and 25 weeks (end) treatment, 6 and 12 months follow-up.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of threshold or subthreshold for Bulimia Nervosa or Binge Eating Disorder (DSM-5/ICD-11) BMI between ≥ 27 and < 40 Exclusion Criteria: Diagnosis of psychosis, bipolar disorder or substance abuse dependence and/or a high level of suicide risk. Use of weight loss medication or medications that interfere with appetite. Cushing or Prader-Willi syndromes History of bariatric surgery Patients who are already in treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angelica Claudino, MD, Ph.D
Organizational Affiliation
Federal University of São Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universidade Federal de Sao Paulo (UNIFESP)
City
Sao Paulo
State/Province
SP
Country
Brazil

12. IPD Sharing Statement

Citations:
PubMed Identifier
28304341
Citation
Palavras MA, Hay P, Filho CA, Claudino A. The Efficacy of Psychological Therapies in Reducing Weight and Binge Eating in People with Bulimia Nervosa and Binge Eating Disorder Who Are Overweight or Obese-A Critical Synthesis and Meta-Analyses. Nutrients. 2017 Mar 17;9(3):299. doi: 10.3390/nu9030299.
Results Reference
background
PubMed Identifier
26683478
Citation
Palavras MA, Hay P, Touyz S, Sainsbury A, da Luz F, Swinbourne J, Estella NM, Claudino A. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial. Trials. 2015 Dec 18;16:578. doi: 10.1186/s13063-015-1079-1.
Results Reference
background
PubMed Identifier
30428611
Citation
Palavras MA, Hay P, Claudino A. An Investigation of the Clinical Utility of the Proposed ICD-11 and DSM-5 Diagnostic Schemes for Eating Disorders Characterized by Recurrent Binge Eating in People with a High BMI. Nutrients. 2018 Nov 13;10(11):1751. doi: 10.3390/nu10111751.
Results Reference
background
PubMed Identifier
35610603
Citation
Hay P, Palavras MA, da Luz FQ, Dos Anjos Garnes S, Sainsbury A, Touyz S, Appolinario JC, Claudino AM. Physical and mental health outcomes of an integrated cognitive behavioural and weight management therapy for people with an eating disorder characterized by binge eating and a high body mass index: a randomized controlled trial. BMC Psychiatry. 2022 May 24;22(1):355. doi: 10.1186/s12888-022-04005-y.
Results Reference
derived
PubMed Identifier
31983019
Citation
Palavras MA, Hay P, Mannan H, da Luz FQ, Sainsbury A, Touyz S, Claudino AM. Integrated weight loss and cognitive behavioural therapy (CBT) for the treatment of recurrent binge eating and high body mass index: a randomized controlled trial. Eat Weight Disord. 2021 Feb;26(1):249-262. doi: 10.1007/s40519-020-00846-2. Epub 2020 Jan 25.
Results Reference
derived

Learn more about this trial

Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED)

We'll reach out to this number within 24 hrs